This study tested the hypothesis that gender affects the presser and r
enal vasoconstrictor responses to angiotensin (Ang) I and Ang II in sa
lt-replete normotensive subjects. Ang I and Ang II were infused in gra
ded doses into 9 men and 8 women in a randomized, single-blind, crosso
ver study. There were no differences between genders in baseline blood
pressure, heart rate, sodium excretion, renal plasma now, angiotensin
-converting enzyme (ACE) genotype, ACE activity, plasma renin activity
, aldosterone, or Ang II levels. Although presser responses to Ang I a
nd Ang II were similar in men and women, there was a negative relation
ship between the change in mean arterial pressure and the change in he
art rate during Ang I and II infusion in women only. The half-time of
the presser response alter discontinuation of Ang I but not Ang II inf
usion was greater in men than in women (9.5+/-2.2 versus 4.3+/-2.1 min
utes, P<.05). This difference in duration did not result from gender d
ifferences in the metabolism of Ang I because Ang II levels measured d
uring Ang I infusion were identical in men and women. In contrast, the
renal vasoconstrictor response to Ang I and Ang II was significantly
increased in women compared with that in men (Ang I, -243+/-31 versus
-138+/-13 U/1.73 m(2); Ang II, -233+/-25 versus -175+/-18 U/1.73 m(2);
P<.03). These data suggest an effect of gender on baroreflex reactivi
ty during angiotensin infusion. Moreover, in the setting of similar An
g II concentrations, the dramatic difference in the renal vasoconstric
tor responses to Ang I and Ang II between salt-replete men and salt-re
plete women suggests gender differences at a pharmacodynamic level.